Skip to main content

Table 6 Antibiotic susceptibility pattern of gram-negative bacterial isolates of an adult patient with lower respiratory tract infection at HUCSH, 2019

From: Bacterial profile and drug susceptibility among adult patients with community acquired lower respiratory tract infection at tertiary hospital, Southern Ethiopia

Isolates

Pattern

Antibiotics (%)

CEF

CAZ

CXT

TAT

CTR

AMP

AUG

CPR

COT

GN

IMP

K. pneumoniae (N = 36)

S

30 (83.3)

13 (36.1)

30 (83.3)

15 (41.7)

24 (66.7)

9 (25.0)

12 (33.3)

33 (91.7)

19 (52.8)

  

I

0

4 (11.1)

0

4 (11.1)

4 (11.1)

8 (22.2)

4 (11.1)

0

1 (2.8)

NA

NR

R

6 (16.7)

19 (52.8)

6 (16.7)

17 (47.2)

8 (22.2)

19 (52.8)

20 (56.6)

3 (8.3)

16 (44.4)

  

Pseudomonas spp (N = 25)

S

23 (92.0)

6 (24.0)

     

17 (68.0)

 

17 (68.0)

16 (64.0)

I

0

2 (8.0)

NR

NR

NR

NR

NR

0

NR

4 (16.0)

2 (8.0)

R

2 (8.0)

17 (68.0)

     

8 (32.0)

 

4 (16.0)

7 (28.0)

E.coli (N = 22)

S

17 (77.3)

11 (50.0)

18 (81.1)

3 (13.6)

14 (63.6)

3 (13.6)

5 (22.7)

13 (59.1)

10 (40.9)

  

I

1 (4.5)

2 (9.1)

2 (9.1)

5 (22.7)

0

0

1 (4.5)

0

1 (45.5)

NA

NR

R

4 (18.2)

9 (40.9)

2 (9.1)

14 (63.6)

8 (36.4)

19 (86.4)

16 (72.7)

9 (40.9)

11 (4.5)

  

Acinetobacter (N = 19)

S

17 (89.5)

13 (68.4)

  

16 (84.2)

  

15 (78.9)

6 (31.6)

16 (84.2)

12 (63.2)

I

0

1 (5.3)

NR

NR

2 (10.5)

NR

NR

1 (5.3)

3 (15.8)

2 (10.5)

2 (10.5)

R

2 (10.5)

5 (26.3)

  

1 (5.3)

  

3 (15.3)

10 (52.6)

1 (5.3)

5 (26.3)

Enterobacter spp (N = 4)

S

4 (100.0)

4 (100)

3 (75.0)

4 (100)

4 (100)

1 (25)

1 (25)

4 (100)

2 (50)

  

I

0

0

0

0

0

0

0

0

0

NA

NR

R

0

0

1 (25.0)

0

0

3 (75)

3 (75)

0

2 (50)

  

Citrobacter spp (N = 2)

S

2 (100.0)

0

1 (50.0)

2 (100.0)

2 (100.0)

0

0

2 (100.0)

1 (50)

  

I

0

0

0

0

0

0

0

0

0

NA

NR

R

0

2 (100.0)

1 (50.0)

0

0

2 (100.0

2 (100.0)

0

1 (50)

  

Total (N = 108)

S

93 (86.0)

49 (45.4)

52 (81.3)

23 (35.9)

60 (72.3)

13 (20.3)

18 (28.1)

84 (77.8)

38 (45.8)

33 (75.0)

28 (63.6)

I

1 (0.9)

9 (8.3)

2 (3.1)

10 (15.6)

6 (7.2)

8 (12.5)

5 (7.8)

1 (0.9)

5 (6.0)

6 (13.6)

4 (9.1)

R

14 (13.0)

50 (46.3)

9 (15.6)

31 (48.4)

17 (20.5)

43 (67.2)

41 (64.0)

23 (21.3)

40 (48.2)

5 (11.4)

12 (27.3)

  1. NA Not applied, NR Not recommended, AUG Augmentin, CAZ Ceftazidime, CXT Cefoxitin, AMP Ampicillin, CEF Cefepime, TAT Tetracycline, CTR Ceftriaxone, CPR Ciprofloxacin, GN Gentamycin, IMP Imipenem, COT Cotrimoxazole, S Sensitivity, I Intermediate, R Resistance